Antibodies Having Specificity for btn2 and Uses Thereof

Inventors

Etienne Foucher, Carla Cano, Kieu Suong LE, Christine Pasero, Daniel Olive

Assignees

1. Aix Marseille Universite
2. Centre National de la Recherche Scientifique CNRS
3. Institut National de la Sante et de la Recherche Medicale INSERM
4. Institut Jean Paoli and Irene Calmettes
5. Imcheck Therapeutics SAS

Abstract

The present invention relates to antibodies having specificity for BTN2A and uses thereof, in particular for the treatment of cancer.

CovalX Technology Used

Epitope Mapping
XL-MS